Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Diego Fidone
Institution:
Mario Negri Institute for Pharmacological Research
Observed institution:
Mario Negri Institute for Pharmacological Research
ORCID:
0009-0009-4469-6058
Observed ORCID:
0009-0009-4469-6058
OpenAlex ID:
A5093579414
Anti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study
2023
·
Piero Ruggenenti
, Linda Reinhard
, et al.
·
American Journal of Kidney Diseases
·
16
PDF
Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD
2025
·
Matias Trillini
, Alessandro Villa
, et al.
·
Kidney International Reports
·
6
PDF
Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy
2026
·
Matias Trillini
, Federica Casiraghi
, et al.
·
Kidney International Reports
·
5
PDF
GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniques
2024
·
Fabiola Carrara
, Flavio Gaspari
, et al.
·
PLoS ONE
·
3
Show more works
View as search
Works count:
4
Citation count:
30
H-index:
3
I10-index:
1
Year
Topic
Type